Aurélie K.
- Country
- France
- Department
- Department of Nuclear Medicine
Research Overview
- Evaluation of diagnostic performances of 18F-FDOPA PET KInetics as biomarkers for the improvement of care of MRI Non-contrast enhanced Gliomas : a phase IIIb exploratory trial
- Evaluation of [18F]-Fludarabine and Gadoteric Acid PET/MR Imaging in Newly Diagnosed Primary CNS Lymphoma Patients Prior to Therapeutic Intervention
Data & Insights
Has run more than one trial at 0 of 14 partner sites.
Specializations
Neuro-Oncology Imaging
This investigator specializes in advanced neurological imaging techniques, particularly focusing on brain tumor diagnostics and central nervous system lymphomas. Their research encompasses innovative approaches in detecting and characterizing various brain malignancies.
- Primary CNS Lymphoma Assessment
- Non-contrast Enhanced Gliomas
- Low Grade Glioma Characterization
Their work involves novel PET-MR imaging applications for brain tumor evaluation.
Molecular Imaging
The investigator advances the field of molecular imaging biomarkers, utilizing sophisticated radiopharmaceuticals for brain tumor assessment. Their expertise includes the evaluation of various PET tracers for neurological applications.
- PET Kinetics Analysis
- Radiopharmaceutical Applications
- Dynamic Imaging Techniques
Their research explores innovative molecular imaging approaches for improved diagnostic accuracy.
Diagnostic Innovation
The investigator develops advanced diagnostic methodologies for neurological conditions, focusing on combining multiple imaging modalities. Their work emphasizes early detection and characterization of brain tumors.
- Multimodal Imaging Integration
- Pre-treatment Assessment
- Diagnostic Performance Evaluation
Their research aims to enhance diagnostic accuracy in neuro-oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.